Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • JdeBruin
    Member
    • Jun 2013
    • 25

    SNP calling on low coverage NGS data

    Hi,

    I am new to SNP calling and would appreciate some input. I want to try and call SNP's for a specific organisms. The hurdles I have is, I do not have a reference genome to map against and I have a very low coverage 4x per organisms.

    Any suggestions would be appreciated.
  • TiborNagy
    Senior Member
    • Mar 2010
    • 329

    #2
    The problem is the following: If you do not have reference genome, you need a de-novo assembly. You can find heterozygous positions in de-novo (which can be called SNPs), but in you case only two reads support this hipothesis.
    So, use this sequences to create a reference and sequence other samples to find SNPs or make a higher coverage sequencing from the initial sample.

    Comment

    • SNPsaurus
      Registered Vendor
      • May 2013
      • 525

      #3
      4X read depth can be even more misleading, since at heterozygous loci you will sometimes get 2 reads per allele, but also 3 reads to one allele vs 1 read for the other, or even 4 reads to one allele and no reads for the other. On the other hand, any allele supported by a few reads is probably real; you just can't fully genotype the sample but you can identify SNPs.

      Genotyping by sequencing was developed to solve this problem. By sequencing only 10,000-100,000 loci across a genome, the reads attain good depth with a small amount of sequencing. We do genotyping by sequencing, as do other companies and academic cores. You don't need a reference for the informatics, but rather the reads can just be compared from sample to sample using a core set of reads representing the loci as a reference.
      Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com

      Comment

      • swbarnes2
        Senior Member
        • May 2008
        • 910

        #4
        You are in trouble. 4x is not enough for de novo assembly, and it is not really enough for calling homozygous SNPs, let alone heterozygous ones.

        If these are all the same species, I'd combine all the reads together, and do de novo assembly on that. Then align each sample's reads to that assembly, call SNPs on those alignments, and realize that you are going to miss most of the heterozygous SNPs, and many homozygous ones too.

        Comment

        • Naibin Duan
          Junior Member
          • Jan 2014
          • 4

          #5
          4X coveragedata without reference is almost impossible to call

          In my opinion,4X coverage reseq-data without any reference is almost impossible to call SNP.
          Best.
          Naibin

          Comment

          Latest Articles

          Collapse

          • mylaser
            Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by mylaser
            Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
            If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
            This guide explains everything you need to know about...
            Yesterday, 01:13 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          19 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          11 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-07-2026, 11:05 AM
          0 responses
          28 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-02-2026, 11:08 AM
          0 responses
          31 views
          0 reactions
          Last Post SEQadmin2  
          Working...